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a b s t r a c t
Supercritical ﬂuid chromatography (SFC) is frequently used for the analysis and separation of non-polar
metabolites, but remains relatively underutilised for the study of polar molecules, even those which
pose difﬁculties with established reversed-phase (RP) or hydrophilic interaction liquid chromatographic
(HILIC) methodologies. Here, we present a fast SFC-MS method for the analysis of medium and high-
polarity (−7≤ cLogP≤2) compounds, designed for implementation in a high-throughput metabonomics
setting. Sixty polar analytes were ﬁrst screened to identify those most suitable for inclusion in chro-
matographic test mixtures; then, a multi-dimensional method development study was conducted to
determine the optimal choice of stationary phase, modiﬁer additive and temperature for the separa-
tion of such analytes using SFC. The test mixtures were separated on a total of twelve different column
chemistries at three different temperatures, using CO2-methanol-based mobile phases containing a vari-
ety of polar additives. Chromatographic performance was evaluated with a particular emphasis on peak
capacity, overall resolution, peak distribution and repeatability. The results suggest that a new genera-
tion of stationary phases, speciﬁcally designed for improved robustness in mixed CO2-methanol mobile
phases, can improve peak shape, peak capacity and resolution for all classes of polar analytes. A sig-
niﬁcant enhancement in chromatographic performance was observed for these urinary metabolites on
the majority of the stationary phases when polar additives such as ammonium salts (formate, acetate
and hydroxide) were included in the organic modiﬁer, and the use of water or alkylamine additives was
found to be beneﬁcial for speciﬁc subsets of polar analytes. The utility of these ﬁndings was conﬁrmed by
the separation of a mixture of polar metabolites in human urine using an optimised 7min gradient SFC
method, where the use of the recommended column and co-solvent combination resulted in a signiﬁcant
improvement in chromatographic performance.
ublis© 2016 The Authors. P
. Introduction
Supercritical ﬂuid chromatography (SFC) as a viable separa-
ion technique was ﬁrst reported by Klesper et al. in 1962 [1];
he decades since have seen a steady increase in its reported
se [2] for an ever-expanding range of applications [3]. However,
nlike liquid chromatography (LC)orgas chromatography (GC), SFC
as remained a niche technique for most of its history, primar-
∗ Corresponding author.
E-mail address: norman.2.smith@kcl.ac.uk (N.W. Smith).
ttp://dx.doi.org/10.1016/j.chroma.2016.04.040
021-9673/© 2016 The Authors. Published by Elsevier B.V. This is an open access article uhed by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
ily used for chiral separations or for preparative chromatography
in industrial settings. Instrumental limitations played an impor-
tant role in slowing the growth of analytical SFC, as many early
instruments exhibited (amongst other issues) poor pump perfor-
mance resulting in unstable backpressures [4]. An important factor
driving the current resurgence of interest in the ﬁeld has thus
been the development of a new generation of SFC instruments,
which provide substantial improvements in system reliability
and performance over their predecessors, and are supplied with
purpose-built interfaces for facile coupling to mass spectrometers
[5]. These new instruments have been developed at a time of sig-
niﬁcant advances in column technology, including the widespread
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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nScheme 1. Experimental design used
vailability of columns packed with sub–3m porous shell
articles and sub–2m totally porous particles [6]. Column man-
facturers have responded to the surge in SFC use by offering
olumns speciﬁcally designed for improved stability in mixed
O2-methanolmobile phases [7]. Considered together, thesedevel-
pments indicate that SFC has the potential to develop into a
ainstream mode of chromatography and, as discussed in a recent
omprehensive review of the technique, may yet become as valued
nd widespread a tool as reversed-phase (RP) LC [8].
SFC is often described as an alternative to normal phase chro-
atography, without the requirement for problematic organic
olvents, such as heptane [9]. Several recently reported achiral SFC
pplications have involved relatively non-polar analytes (e.g. var-
ous classes of lipids [10–12], organic pesticides [13], fat-soluble
itamins [14] etc.). Polar analytes have been more sparingly stud-
ed, even though Berger and others have shown that moderately
olar pharmaceutical compounds can be separated on polar sta-
ionary phases by the addition of organic co-solvents (‘modiﬁers’)
ontaining selected additives to the CO2 mobile phase [15]. Mod-
ﬁer addition can increase the solubility of polar analytes in the
obile phase, and via adsorptive processes can alter station-
ry phase characteristics with consequent changes in retention,
electivity and efﬁciency [9,16]. Methanol is a popular choice as
obile-phase modiﬁer in SFC, as it has been shown to improve the
fﬁciency and peak shape for polar analytes on a variety of station-
ry phases; this improvement has been attributed to the superior
ydrogen-bonding ability of methanol in comparison to other
estedmodiﬁers suchasacetonitrile [17].Modiﬁerenrichmentwith
eutral, acidic or basic additives has also been shown to reduceromatographic method development.
peak tailing and retention for polar analytes to different extents,
depending upon the additive type aswell as analyte characteristics,
including their octanol/water partition coefﬁcients, relative acid-
ity, molecular size and functional group topology [18–20]. These
ﬁndings have led to the suggestion that, with the appropriate com-
bination of stationary phase, modiﬁer and modiﬁer additive, SFC
methods can be developed to replace many RPLC or hydrophilic
interaction liquid chromatography (HILIC) methods for polar com-
pound analysis [8].
One potential application area for SFC is metabolic phenotyp-
ing, also commonly referred to as metabonomics or metabolomics.
Metabolicphenotypingdeterminesmetaboliteproﬁles forbioﬂuids
and tissues in order to detect systemic responses to pathophys-
iological stimuli and to derive a comprehensive, systems-level
understanding of health and disease [21]. Both targeted and untar-
geted metabolic phenotyping are beginning to be applied to very
large-scale studies (ranging from many hundreds to thousands
of samples), derived from preclinical, clinical and epidemiologi-
cal investigations. Currently, the major analytical platforms used
in metabolic phenotyping include nuclear magnetic resonance
(NMR) spectroscopy, as well as GC and UHPLC coupled with mass
spectrometry (i.e. GC–MS, UHPLC–MS) [22]. For UHPLC–MS-based
proﬁling of polar, hydrophilic metabolites, HILIC and ion-pair
chromatography (IPC) have been employed with some success.
However, the analysis of hydrophilicmetabolites remains challeng-
ing, since HILIC is not a solution for all compounds, and IPC can lead
to problematic long-term contamination of the MS [23]. This rep-
resents a major difﬁculty for metabolic phenotyping, as many of
these chromatographically challenging metabolites represent key
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Fig. 1. A shows the composition of the polar analyte library screened for test compound identiﬁcation. A cLogP-based colorscale has beenused inA, with yellow corresponding
to higher cLogP values and dark red corresponding to the lower cLogP values; maltose and maltotriose had the highest molecular weights in the library, while caffeine and
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ntermediates within important anabolic and catabolic biological
rocesses, such as central carbon metabolism. At present, the lack
f readily implementable LC-based technologies for the compre-
ensive and routine proﬁling of these compounds is therefore a
igniﬁcant constraintonourability tomonitor somebasicbiochem-
cal differences between normal and diseased (e.g. cancerous) cells.
ew separation strategies such as SFC,which increasemetabolome
overagewhile reducing solvent requirements, are consequently of
reat interest to metabolic phenotyping studies.
Here, we report the development of an SFC-MS method for the
nalysis of polar analytes in urine, designed for implementation
n a high-throughput metabolic phenotyping environment. An ini-
ial compound screening study, to identify polar analytes suitable
or use in chromatographic test mixtures, was followed by a com-
rehensive method development study, designed to identify the
est choice of stationary phase, modiﬁer additive and tempera-
ure for the separation of test compounds using SFC. A total of
welve columns, nine modiﬁer additives and three temperatures
ere tested during method development; methanol was used as
he organic modiﬁer throughout the study, with orthogonality and
electivity considerations driving the selection of both column and
odiﬁer additive. The chromatographic performance of each eval-
ated set of conditions (column, modiﬁer and temperature) was
udged based on calculated peak base widths, total resolution and
henormalisedproductof the resolution,with theﬁrst twoparame-
ers used to compare relative peak capacities across conditions. The
esults suggest that a new generation of bridged ethylene hybrid
BEH) stationary phases, speciﬁcally designed for SFC analysis, is
articularly well suited for the separation of a wide range of polar
nalytes, with diol and 2-picolylamine chemistries yielding sig-
iﬁcant improvements in chromatographic performance. It was
lso observed that the presence of ammonium formate, water or
mmonium hydroxide in the methanol modiﬁer can substantiallye by co-solvent; the percentage of analytes elutingwith acceptable peak descriptors
erences to colour in this ﬁgure legend, the reader is referred to the web version of
improve chromatographic separation of highly polar metabolites.
In addition, the use of alkylamines as modiﬁer additives is strongly
recommended for the analysis of basic analytes when the SFC is
coupled to a UV–vis detector. The utility of these ﬁndings was con-
ﬁrmed by separating a subset of polar analytes in human urine
using the Torus Diol column with 20mM ammonium formate in
methanol as an organic modiﬁer, and comparing the results to
conditions currently in general use for polar analyte separation on
SFC.
2. Materials and methods
2.1. Solvents and solvent additives
LC–MS (Chromasolv) grade methanol, acetonitrile and iso-
propanol were purchased from Sigma-Aldrich (Poole, UK); water
was obtained from an ultra-pure water puriﬁcation system (Milli-
pore, UK) and ‘food fresh’ liquid CO2 (99.8% purity) was obtained
from BOC (UK). Formic acid (98%), acetic acid (for LC–MS), ammo-
nium formate (≥99.0%), ammonium acetate (≥99.0%), ammonium
hydroxide solution (∼10% in water, for HPLC), isopropylamine
(99%), isobutylamine (99%) and isopentylamine (99%) were also
purchased from Sigma.
2.2. Compound library screening
2.2.1. Composition of screened library
Table S1 lists all sixty polar compounds tested during the com-
pound screening study; these were obtained as pure solids of ≥95%
purity from Sigma, with the exception of l-histidine and cytosine,
whichwerepurchased fromAlfaAesar (Heysham,UK). The selected
compounds covered a cLogP range (calculated using ChemAxon
[24]) from +1.2 to −6.5, a cLogD range (calculated using a pH of
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.5 and the ACD/Labs Percepta platform [25]) from 0.3 to −6.2,
nd molecular weights up to 505Da 5mL stock solutions of each of
he 60 analytes were prepared in water or methanol and stored at
20 ◦Cbeforeuse. Immediatelyprior to analysis, the stock solutions
ere diluted in 1:1 methanol:water to obtain a 10g/mL solution
f each analyte; 1L of this dilute solution was injected onto the
olumn for analysis.
.2.2. Chromatography for library screening
Compound screening was performed on a Waters ACQUITY
PC2, consisting of a binary solvent manager, a sample manager
eld at 4 ◦C and ﬁtted with a 10L injection loop, an insulated col-
mn compartment with an active pre-heater and column heater,
PDA detector ﬁtted with an 8L ﬂow-cell, and a convergence
anager containing an automated backpressure regulator (ABPR)
ith both static and dynamic components to control post-column
ystempressure. All injectionswere performed inpartial loop (nee-
le overﬁll) mode, and PDA data were collected between 190 and
00nm for all analyses.
Compounds were analysed on a fully-porous 3.00×100mm,
.7m ACQUITY UPC2 BEH 2-ethylpyridine (BEH 2-EP) column
aintained at 35 ◦C, using a mobile phase composed of CO2 (sol-
ent A) and the selected organic modiﬁer (solvent B) with the
ollowing 14.65min gradient elution method: the mobile phase
omposition changed from 98% A at 0min to 50% B at 10min, was
eld at 50% B for 1min, then returned to 98% A in 0.65min, fol-
owed by re-equilibration at initial conditions till the end of the
un. The ﬂow-rate was 1mL/min or 1.2mL/min, depending upon
ig. 2. Effect of additive selectiononchromatographicperformance in SFC-MS.A shows the
ll evaluated columns and temperatures) with co-solvent additive. C illustrates the impro
s a modiﬁer additive rather than 0.5% v/v formic acid (FA). Both TIC chromatograms s
:cytosine and 5:cytidine) on a Torus Diol column (3.00 i.d.×100mm, 1.7m dP) at 40
dditive selection on peak base widths for all 7 columns in the initial test set, further expa
owest median peak width value. (For interpretation of the references to colour in this ﬁg1449 (2016) 141–155
whether isopropanol or methanol (respectively) was used as mod-
iﬁer. Four different organic modiﬁers were used to analyse each
compound, viz. 5% v/v water in methanol, 20mM ammonium for-
mate in methanol, 0.2% v/v formic acid in methanol and 7% v/v
water in isopropanol. Each of these modiﬁers and additives has
been successfully employed elsewhere for SFC analysis of polar
moieties [26,15].
2.2.3. Mass spectrometry for library screening
The Waters UPC2 was coupled to a Waters Quattro Premier
tandem mass spectrometer via a purpose-built, two-part stainless
steel splitter supplied by Waters. The ﬂow from the PDA detector
was mixed with 0.2mL/min makeup solvent (0.1% v/v formic acid
in methanol), supplied by a Waters 515 HPLC pump, and the ABPR
was used to maintain the resultant solvent stream at a pressure of
2000 psi (138bar) throughout the run. The pressurised stream was
directed into the ESI sample capillary via a length of 50m PEEKsil
tubing.
Compounds were detected by selected ion recording (SIR) in
either positive or negative ESI MS mode, based on the known
ionisation preference or optimal ionisation mode for each ana-
lyte. Source conditions in positive mode were as follows: capillary
voltage 3.5 kV, cone voltage 30V, source temperature 120 ◦C, desol-
vation temperature 250 ◦C, cone gas ﬂow 300L/hr and desolvation
gas ﬂow 700L/hr. Source conditions for negative mode were as
follows: capillary voltage 3.0 kV, cone voltage 30V, source temper-
ature 100 ◦C, desolvation temperature 250 ◦C, cone gas ﬂow50L/hr,
desolvation gas ﬂow 500L/hr. Analyser collision cell entrance and
variation inpeakbasewidths andB thedifferences in the sumof the resolutions (for
vement in separation observed when using 20mM ammonium formate (AmForm)
how separation of the nucleobase test mixture (1:caffeine, 2:uracil, 3:adenosine,
◦C, using the 7.35min gradient described in Section 2.3.4. D shows the effect of
nding on the data shown in A; n=30 for all plots and the red asterisks indicate the
ure legend, the reader is referred to the web version of this article.)
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xit voltages were set at 50V, with the collision cell voltage set at
V. SIR data was collected with a dwell time of 0.05 s and a cone
oltage of 30V (this was found to be suitable for the majority of
nalytes studied). Data acquisition, data handling and instrument
peration were controlled by MassLynx (v. 4.1 from Waters, Mil-
ord MA, USA); raw SFC-MS and SFC-PDA data was subsequently
rocessed and analysed using TargetLynx, a MassLynx module.
.3. Method development
Scheme 1 illustrates the experimental design followed dur-
ng chromatographic method development. An initial set of eight
olumns were screened in nine co-solvent additives and at three
emperatures, with results evaluated based on improvements in
eak capacity and peak distribution (cf. Section 3.2). The four Torus
olumns were released in October 2014, after the study had com-
enced; in order to minimise the total number of experiments,
hese columns were accordingly only screened in the three MS-
ompatible modiﬁers that had yielded the best performance till
hat date. In addition, changing the temperature in the range ini-
ially selected for evaluation (35–45 ◦C) did not lead to signiﬁcant
lterations in peak width or distribution. Consequently, the Torus
olumns were evaluated at one additional temperature, 55 ◦C, in
he three selected co-solvents. Thus a total of 264 unique combina-
ions of column, modiﬁer additive and column temperature were
ested as part of the method development study.
.3.1. Test mixture preparation and extraction of human urine
In the initial compound screening study, eleven compoundsere identiﬁed as ‘responders’, which eluted in all four organic
odiﬁers with acceptable k values and peak symmetries. An addi-
ional nine compounds eluted in all four modiﬁers with either a
or a b/a value that fell outside the acceptable limits for a ‘hit’;inued)
these were considered to be ‘sub-responders’. The eleven respon-
ders and nine sub-responders (a total of twenty compounds) were
subsequently incorporated into ﬁve different test mixtures in 1:1
methanol:water, as described in Table S2.The test mixtures were
designed to cover a range of cLogP values and compound classes,
and all contained caffeine as an internal standard for the measure-
ment of analytical repeatability. Test mixtures were prepared in
bulk as 25mL solutions, and stored in 1mL aliquots at −20 ◦C until
immediately before analysis.
For the separation of analytes in human urine, urine samples
were obtained from healthy individuals and pooled to form a ref-
erence urine sample; this was spiked with caffeine, uridine and
cytosine as aqueous stock solutions. The spiked urine was then
mixed with methanol in a 1:3 urine:methanol ratio, vortexed for
30 s at roomtemperature, andcentrifugedat 700gat 4 ◦C for10min.
The centrifuged sample was divided into 1mL aliquots and stored
at −80 ◦C, then thawed immediately prior to analysis.
2.3.2. Stationary phases
All columns screened during method development had dimen-
sions of 3.00mm i.d.×100mm, and were obtained from Waters
(Milford, USA). In all, twelve fully-porous columns were tested,
including four Acquity UPC2 columns (BEH 2-EP, BEH, CSH FP and
HSS C18 SB), four Acquity UPLC columns (BEH Amide, BEH HILIC,
BEH Phenyl and HSS Cyano), and four Acquity UPC2 Torus columns
(2-picolylamine or 2-PIC, Diol, Diethylamine or DEA and 1-amino
anthracene or 1-AA). Of these, only the HSS columns had a particle
size (dp) of 1.8m, the remainder having a dp of 1.7m.
The columns were tested for compliance with manufacturer
QC speciﬁcations, and equilibrated in 100% CO2 at 1mL/min for
60min before initial use. Column performance was monitored
at the start of each day of analysis using repeated injections of
caffeine, adenosine and toluene (used as an approximate measure
146 A. Sen et al. / J. Chromatogr. A 1449 (2016) 141–155
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hile B illustrates NPR variation across columns (for water, ammonium formate an
ight gray, Torus UPC2 columns are in dark gray and UPLC columns are in white.
f column dead-volume by UV [27]) and an isocratic method with
% (v/v) water in methanol as the organic modiﬁer. Between analy-
es, columns were washed with 1:1 CO2:methanol at 1mL/min for
0min, then stored in 100% CO2.
.3.3. Modiﬁer preparation
Methanol was used as the organic modiﬁer throughout the
ethod development phase, and contained one of nine different
dditives at a concentration of 0.5% v/v (for formic acid, acetic acid,
sopropylamine, isobutylamine and isopentylamine), 20mM (for
mmonium formate, acetate and hydroxide), or 5% v/v (for water).
ll modiﬁer solutions were prepared volumetrically or, in the case
f the ammoniumsalts, by additionof the solid salt to themethanol,
ollowed by sonication at room temperature for 10min.
.3.4. Chromatography for method development
A 7.35min gradient elution method was used for all method
evelopment analyses, viz. 98% CO2 at 0min to 50% CO2 at 4min,
eld at 50% CO2 for 1.5min, then returning to 98% CO2 in 0.8min
nd re-equilibration till the end of the run; the column was held
t the relevant temperature (35, 40, 45 or 55 ◦C) and the ﬂow-rate
askept constant at1.0mL/min throughout the run. Prior to all gra-
ient analyses, columns were equilibrated at 1mL/min for 20min
>10 column volumes) at initial gradient conditions. 4×1L injec-
ions of caffeine were then made, and the observed retention time
tability and peak area variation under gradient conditions were
sed to conﬁrm column equilibration. This was followed by 2L
njections of each test mixture. For human urine analysis, the same
hromatographic gradient was used on both the BEH 2-EP and the
orus Diol columns at 40 ◦C, using either 5% water in methanol oron in NPR across modiﬁer additives (for all evaluated columns and temperatures),
ic acid-containing modiﬁers, at all evaluated temperatures); UPC2 columns are in
20mM ammonium formate in methanol as modiﬁer; 1L aliquots
of 1:3 urine:methanol extract were injected onto the column.
2.3.5. Mass spectrometry for method development
MS analysis for method development was performed in ESI pos-
itive mode, with instrument conﬁguration, source and analyser
settings as given in Section 2.2.3, with the following modiﬁcations:
extractor voltage 5V and RF lens voltage 0.2V. The ﬂow from the
PDAdetectorwasmixedwith 0.3mL/minmakeup solvent (0.1% v/v
formic acid in methanol), supplied by a Waters 515 HPLC pump,
before entering the MS source; the ABPR was held at 2000 psi
(138bar) for all analyses. When alkylamines were used as modiﬁer
additives, the UPC2 was used in stand-alone mode i.e. with UV–vis
detection only.
2.3.6. Data analysis
Retention time (tR), peak area, peak base width, peak asymme-
try (b/a) and signal-to-noise (S/N) values for each analysis were
obtained by processing the raw data in TargetLynx. Further sta-
tistical treatment was performed in R [28]. Venn diagrams were
generated using the VennDiagram package [29]. Tukey-style box-
plots (with no outliers shown) were generated using the default
graphics package, with whiskers extending to (at a maximum) 1.5×
the inter-quartile range (IQR); n values accompanying each box-
plot or in the ﬁgure captions describe the number of data points
included per condition.
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. Results and discussion
.1. Screening of polar urinary metabolites for test compound
dentiﬁcation
For the planned SFC method development study, it was neces-
ary to identify a set of representative polar compounds that eluted
ith reasonable peak shapes and retention times in a variety of
outinely-used chromatographic conditions. Accordingly, a library
f 60 polar analytes of known biological signiﬁcance or clinical rel-
vance was screened using a BEH 2-EP column and an SFC gradient
ethodwithoneof fourdifferent organicmodiﬁers. The compound
ibrary (Fig. 1A, Table S1) included nucleobases and related com-
ounds (e.g. uracil, adenosine, cytosine and cytidine), amino acids
e.g. methionine, tryptophan, lysine etc.,), organic acids (such as
-aminobutyric acid, lactic acid) and sugars (such as glucose, galac-
ose). The BEH 2-EP column was chosen for compound screening
ince it has been widely used for SFC separations of polar analytes.
imilarly, the four selectedmodiﬁers have previously been used for
olar compound analysis by SFC [26,15].
Any analyte which eluted with an acceptable peak shape (as
easured by b/a <4), 2 ≤k≤20 and a S/N≥3 in either MS mode
as considered to be a ‘hit’; Fig. 1B summarises the corresponding
it-rate for all tested modiﬁers. Compounds that were ‘hits’ in all
odiﬁers were classiﬁed as ‘responders’, and subsequently formed
he basis of chromatographic test mixtures for SFC method devel-
pment. ‘Non-responders’ were those compounds for which peaks
ig. 4. Effect of alkylamine additives on chromatographic performance in SFC (UV-vis dat
f the resolutions (across all evaluated columns and temperatures); the N value of 267 i
llustrates the improvement in separation observed when using 0.5% v/v isobutylamine (I
how separation of the nucleobase test mixture (1:uracil, 2:adenosine, 3:cytidine, 4:cyto
.35min gradient described in Section 2.3.4. D shows the effect of additive selection on pe
n A; n=39 for all plots and the red asterisks indicate the lowest median base width valu
eferred to the web version of this article.)1449 (2016) 141–155 147
were not observed in the presence of anymodiﬁer, in anyMSmode,
andwere accordingly left out of chromatographic testmixtures. Fig.
S1 provides further details regarding the distribution of responders
and non-responders in the various tested modiﬁers and MS modes.
3.2. Evaluation of chromatographic conditions
Having selected a suitable subset of polar analytes for test mix-
ture preparation, a method development study was performed to
evaluate chromatographic performance in a total of 264 unique
combinations of column, modiﬁer additive and column tempera-
ture. The resultant datasetwas information-rich and complex,with
a wide range of peak base widths and retention times exhibited by
the twenty analytes across the tested conditions. In order to reduce
this complex dataset to a more tractable form, it was necessary to
identify criteria that would simplify evaluation and comparison of
the separation quality. As high-throughput untargeted LC- or SFC-
MSmetabolic phenotyping studies require highpeak capacities and
resolutionwithin a short analysis time, the quality of separation for
each combination of column, modiﬁer and temperature was evalu-
atedbasedon threeparameters: peakbasewidth, sumof resolution
and the normalised product of the resolution.The peak base width may be related to peak capacity as follows:
Pc = 1 +
tg
1
n
∑n
1wp
(1)
a only). A shows the variation in peak base widths and B the differences in the sum
n A reﬂects the fact that some analytes were present in multiple test mixtures. C
soButAm) as a modiﬁer additive rather than 5% water (Wat). Both chromatograms
sine) on an HSS Cyano column (3.00 i.d.×100mm, 1.8m dP) at 40 ◦C, using the
ak base widths for 4 representative columns, further expanding on the data shown
e. (For interpretation of the references to colour in this ﬁgure legend, the reader is
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here Pc is the peak capacity for a gradient of length tg , and wp
s the base width for each of n peaks used in the calculation [30].
nother common deﬁnition of peak capacity uses the sum of the
esolution (Rs) across the chromatogram:
c = 1 +
∑
n
RS (2)
here RS is the resolution between peaks, calculated here using Eq.
3):
S =
2
(
tr,1 − tr,2
)
(
wp,1 + wp,2
) (3)
here wp,n is the peak width for the nth peak, eluting at reten-
ion time tr,n. Both deﬁnitions for peak capacity have constraints
n their use to describe gradient separations (e.g. Eq. (2) applies
o situations where peak widths follow a similar pattern across
he chromatogram [30]), but are sufﬁcient for our purpose viz.
omparison of separation quality under different chromatographic
onditions.
Thus, based on Eqs. (1) and (2), the average peak base width
nd the average Rs may be used to compare the relative peak
apacities of the evaluated chromatographic conditions. In the cur-
ent analysis, we have chosen to compare peak base width and
esolution data using the boxplot representation, and hence are
omparing the median rather than the average parameters across
onditions; however, where relevant, we have also provided mean
alues within the text.
One shortcoming of peak capacity as an estimate of chromato-
raphic performance is that it does not take into account the
istribution of peaks across the chromatographic window. While
inimising peak base width and increasing resolution are crucial
or improved separation inmetabolic proﬁling studies, an even dis-
ribution of peaks across the retention time range ensures a moreinued)
efﬁcient use of chromatographic space. To evaluate peak distribu-
tion, Schoenmakersandothershaveused thenormalised resolution
product (r or NPR) [31]:
r =
∏
n
(RS/R¯S) (4)
where R¯S is the mean resolution for n peaks. Thus for n peaks, each
with the same RS , the r would have a value of 1; separations with a
more uneven distribution of peaks would have values r « 1. By con-
sidering the peak capacity together with the r, a separation can be
simultaneously optimised for greater analyte resolution and more
even feature distribution.
In the following sections, boxplots comparing peak base widths
across modiﬁers or columns are based on data for a subset of
polar analytes which eluted with reasonable peak shapes and k
values in all investigated conditions, viz. 2-aminobutyric acid, ade-
nine, adenosine, creatinine, cytosine, hippuric acid, leucine, proline,
uracil and xylitol. These analytes were selected in order to com-
paremodiﬁers or columnswith different totalnumbers of observed
peaks i.e. in order to ensure that the comparison was based upon
peaks observed in all evaluated conditions. On the other hand, the
sum of resolution for each condition was necessarily calculated
based on all observed peaks. Similarly, the r calculations used data
from all observed peaks per condition. Note that the BEH Phenyl
phase is excluded from all column performance evaluation plots
shown below, due to the extremely poor peak shapes and separa-
tion observed when it was used for this set of analytes, regardless
of the modiﬁer additive or temperature used.3.2.1. Effect of modiﬁer additives
A total of nine modiﬁer additives were tested during method
development; of these, water, formic acid, acetic acid and the
ammonium salts were MS-compatible. The remaining three
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dditives were alkylamines, and their use was consequently
estricted toSFC-UV–vis only. The impact of additive selectionupon
eak basewidths and resolution in SFC-MSmode is shown in Fig. 2:
he three ammonium salts reduce themedian peak basewidth con-
iderably when compared to the acidic additives. This reduction
s particularly pronounced for nucleobases and amines, in keep-
ng with the basic nature of the ammonium salt additives. Thus
he addition of ammonium hydroxide to the modiﬁer resulted in a
edian peak base width of 17.3 s, as opposed to formic acid with
median width of 33.9 s (mean values are 26.5 and 46.6 s respec-
ively). The use of ammonium formate and water also resulted in
arrower peaks, with median widths of 19.4 (mean of 25.6 s) and
0.1 s (mean of 33.2 s) respectively. As illustrated by Fig. 2C and D,
hese general trends are evident in the performance of individual
olumns, andareevenmorepronounced for speciﬁc columns.How-
ver, the sum of resolutions (Rs) was not signiﬁcantly enhanced
y any additive, ranging from a median value of 4.0 for ammonium
cetate to 4.7 forwater (Fig. 2B). In addition, peak distributionmea-
ured by r (Fig. 3A) followed a different trend, with the most even
istribution seen for ammonium acetate (median r of 0.39, mean of
.42), and the most uneven observed for ammonium formate and
ater, with median r values of 0.23 and 0.20 respectively. Differ-
nt modiﬁer additives may thus be chosen based on the desired
utcome e.g. ammonium acetate for more even peak distribution,
mmonium hydroxide for reduction in peak width, or ammonium
ormate for reduced peak widths across a wider range of analytes.
ig. 5. Effect of column selection on chromatographic performance in SFC-MS. A shows
across water, ammonium formate and formic acid-containing modiﬁers and all evaluated
n dark gray and UPLC columns are in white. C illustrates the improvement in separation
hromatograms show separation of the nucleobase test mixture (1:caffeine, 2:uracil, 3:ad
s a modiﬁer at 40 ◦C, using the 7.35min gradient described in Section 2.3.4. D shows th
urther expanding on the data shown in A; n=45 for all plots and the red asterisks indicate
n this ﬁgure legend, the reader is referred to the web version of this article.)1449 (2016) 141–155 149
These results are, for the most part, in agreement with pre-
vious studies showing the utility of volatile ammonium salts for
SFC-MS separation of polar molecules. Both ammonium formate
and ammonium acetate increased the elution of highly polar
pharmaceutically-relevant analytes from a cyano column [19], and
both were found to improve chromatographic peak shapes for a
range of doping agents separated on BEH and BEH 2-EP columns.
The latter study also tested the variation in MS response with
modiﬁer additive and found that, in comparison to formic acid or
ammonium hydroxide, both ammonium acetate and ammonium
formate improved signal intensity for the majority of tested doping
agents. Furthermore, the combination of ammonium formate with
a small percentage (2% v/v) of water resulted in additional gains in
signal intensity, and this combinedmobile phasewas subsequently
used for the analysis of 110 doping agents in human urine by SFC-
MS [32]. The current basewidthdata supports theuseofwater as an
additive to improve peak shapes for acids and sugars, while its use
has previously been demonstrated to give sharper peaks for nucle-
obasesonavarietyof stationaryphases, includingdiol, cyanopropyl
and 2-EP [26]. In the current study, cytidine, the most strongly
retained of the nucleobases tested, only eluted from the amide col-
umn when 5% water was used as an additive: this supports the
ﬁndings of Taylor and other groups, and suggests that water could
be used in combination with other additives to improve separation
of the most polar analytes [20,26]. Hamman et al. have demon-
strated that 0.1% ammonium hydroxide in methanol as a modiﬁer
the variation in peak base widths and B the differences in the sum of resolutions
temperatures) by column. UPC2 columns are in light gray, Torus UPC2 columns are
observed when using a Torus Diol column rather than a BEH 2-EP column. Both TIC
enosine, 4:cytosine and 5:cytidine) using 20mM ammonium formate in methanol
e effect of column selection on peak base widths for 3 representative co-solvents,
the lowest median base width value. (For interpretation of the references to colour
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mprovespeak shapeanddecreases retentionof basic drugsonboth
thylpyridine and diol columns [33], and have also tested the sta-
ility of silica-supported chiral stationary phases in the presence
f this modiﬁer under SFC conditions. Their results suggest only
inor stationary phase degradation occurs over 100,000 column
olumes. Thus, the four additives with the greatest reduction in
edian peak base width (ammonium formate, acetate, hydroxide
ndwater) should all be considered for the analysis of polar urinary
etabolites by SFC-MS, with the ﬁnal choice of additive (or addi-
ive combination) determined by the desired outcome, such as the
argeted analysis of a speciﬁc compound class.
The three alkylamine additives were tested using UV–vis (PDA)
etection only, due to concerns regarding ion suppression and
S source contamination. Their impact on chromatographic per-
ormance was evaluated based on the separation of the seven
V-active analytes present in the test mixtures viz. adenine,
denosine, creatinine, cytidine, cytosine, hippuric acid and uracil.
lkylamines have been used extensively as ion-pairing agents in
C, to increase retention and improve peak characteristics for
mall, basic analytes. Berger and Wilson showed that baselineinued)
resolution of drug mixtures (including a series of anti-depressants,
anti-psychotics and stimulants) could be obtained by adding 0.5%
v/v isopropylamine to amethanol-based SFCmobile phase [34–36],
while De Klerck et al. have used isopropylamine in conjunction
with TFA to increase enantioresolution in chiral SFC [37]. Simi-
larly, Regalado et al. used 25mM isobutylamine as an additive in
methanol for chiral and achiral SFC separations of a variety of drugs
anddrugmetabolites [38]. Thus, both isobutyl- and isopropylamine
were included in our modiﬁer screen, along with isopentylamine
to determine if the size of the alkyl side-chain contributes to chro-
matographic performance in SFC.
The reduction in median peak base width obtained upon addi-
tion of alkylamines to the mobile phase is shown in Fig. 4. The
UV–vis data showed consistently narrower peaks than the MS
data, as is evident when comparing median peak widths for the
methanol/5% water modiﬁer in Figs. 2 A and 4 A. This difference
between MS and UV data may indicate that further optimisation
of MS settings and/or system volumes between column outlet and
MS inlet is required. As shown in Fig. 4A, both the median peak
base width and the peak base width range across conditions was
togr. A
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igniﬁcantly reduced in the presence of the alkylamine additives,
hen compared to results obtained with methanol/5% water as a
odiﬁer (the latter had a median peak base width of 7.0 s). The
eduction in peak base width followed a clear trend based on the
ize of the alkyl side-chain, with isopropylamine showing the low-
st median width (4.5 s) and isopentylamine showing the highest
5.0 s). Themedian Rs parameter decreased in the same direction,
rom4.0 s for isopropylamine to 3.1 s for isopentylamine.Mean val-
es for both peak base widths and Rs followed the same trends.
hese results are in keeping with the ﬁndings of Berger, Regalado
nd others, and suggest that alkylamine additives should be con-
idered for SFC-UV–vis analysis of polar metabolites. Furthermore,
hile the evaluated alkylamines dramatically improve separation
n all columns (except BEH Amide), smaller branched-chain alkyl
roups appear to be preferable to larger ones. Amine additives
re expected to decrease non-speciﬁc interactions between ana-
yte and stationary phase by masking exposed silanols [39]. Thus,
he observed size-dependent trend indicates that increasing the
ulk of the akyl group reduces the interaction between amine
nd silanol groups, reducing the masking effect seen with smaller
lkyl groups. As Fig. 4D illustrates, these general ﬁndings are also
alid in the case of individual columns, with some exceptions:
he use of isopentylamine as an additive resulted in the narrow-
st peaks for the BEH 2-EP column, while it was water rather than
he alkylamines that provided the greatest decrease in peak widths
or the BEH Amide column (7.1 s for water vs. 20.7 for isopenty-
amine).
ig. 6. Effect of temperature on chromatographic performance in SFC-MS. A shows the va
ater, ammonium formate and formic acid-containing modiﬁers and all Torus columns
hen using a Torus DIOL column at 55 ◦C rather than at 35 ◦C. Both TIC chromatograms
:cytosine and 5:cytidine) using 20mM ammonium formate in methanol as a modiﬁer a
shows the effect of temperature selection on peak base widths for the Torus columns,
ndicate the lowest median base width value. (For interpretation of the references to colo1449 (2016) 141–155 151
3.2.2. Effect of column chemistry
A total of twelve stationary phases were evaluated during
method development. Of these, eight were columns speciﬁcally
marketed for SFC use, while the remaining four were columns for
use with RPLC or HILIC separations on UHPLC systems. The tested
SFC columns included both the recently introduced ACQUITY UPC2
Torus columns, designed for improved robustness and stability in
mixed CO2-methanol mobile phases [7,40], and the older ACQUITY
UPC2 range. The effect of column selection on peak widths and on
the sum of resolution across a range of modiﬁers and tempera-
tures in summarised in Fig. 5, while Fig. 3B shows the differences
in r due to column type. From Fig. 5A it is evident that the great-
est reduction in peak base width was obtained by use of the Torus
range of columns (in dark grey), and that the peaks on this col-
umn range were generally narrow. The Diol column had the lowest
median peak width of 12.6 s (mean of 14.1 s), though the 2-PIC col-
umn had a very similar median width (13.4 s) (mean of 15.3 s). The
only non-Torus columns to show comparable median peak width
reduction and peak width range were the HSS C18 SB and BEH 2EP
columns (median widths of 17.4 for both); however, as is evident
in Fig. 5C, peak resolution on the Diol column was markedly bet-
ter than on the BEH 2-EP column. The UPLC columns (in white)
showed slightly higher median peak widths, but the variation in
2values across conditions was much higher than for the Torus UPC
columns. The largest variation in peak width was observed for the
CSH FP column, which also showed a relatively uneven distribu-
tion of peaks (Fig. 3B). The trend in peak width values was also
riation in peak base widths and B the differences in the sum of resolutions (across
) by temperature. C illustrates the change in peak width and resolution observed
show separation of the nucleobase test mixture (1:caffeine, 2:uracil, 3:adenosine,
t the relevant temperature, using the 7.35min gradient described in Section 2.3.4.
further expanding on the data shown in A; n=33 for all plots and the red asterisks
ur in this ﬁgure legend, the reader is referred to the web version of this article.)
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een for every compound class, with both Diol and 2-PIC columns
howing signiﬁcant reductions in peak width for all classes of ana-
yte. Indeed, all Torus columns showed marked reductions in both
edian peak base widths and the base width variation (range) for
ll tested analyte classes. When column performance was com-
ared in individual co-solvents (Fig. 5D) it became apparent that
he overall trends observed in Fig. 5A and B were also applicable in
peciﬁc cases: the Diol column had the lowest median peak widths
n the presence of water and ammonium formate (12.6 and 11.3 s
espectively), while the 2-PIC columnhad the lowestmedianwidth
n formic acid (13.7 s). Note that Fig. 5D also demonstrates the ben-
ﬁcial effect of using ammonium formate as an additive for this set
f analytes, with narrower peak widths observed across all column
ypes in the presence of this additive.
Of the Torus columns, the Diol column also had the highest
edian Rs value (7.8) in keeping with the peak base width reduc-
ion, and a relatively high median r of 0.39 (Fig. 3B). In general, the
ore even peak distributions were observed for the Torus columnswith the exception of the 2-PIC), the BEH HILIC and HSS Cyano
olumns, while the BEH Amide and CSH FP had the most uneven
istributions. Thus the Torus columns, and in particular the Diolinued)
column, offer improved resolution due to narrower peak base
widths for all classes of polar analyte, and a relatively even dis-
tribution of peaks across the retention time range.
3.2.3. Effect of temperature
The temperature range initially evaluated (35–45 ◦C) was
selected because it encompasses the common operational tem-
perature range for untargeted LC–MS-based urine metabolomics
[41], and is also well below the maximum recommended temper-
ature for the majority of screened stationary phases (60 ◦C for the
UPC2 columns and 90 ◦C for the UPLC columns). The ABPR pressure
setting used (2000 psi/138bar) ensured that on-column phase sep-
aration of the methanol-CO2 mixture was not expected to occur in
the evaluated temperature range [42], and the relatively high pro-
portion of modiﬁer meant that the mobile phase density remained
predominantly liquid-like during the gradient run. Thus, increasing
the temperature canbeexpected to impact retentionandresolution
in a similar manner as in LC.
All three temperatures initially studied showed similar median
peak base width and Rs values, with no deﬁnite trend observable
for any particular class of compound (Fig. S2A and B). The results
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mig. 7. Results of method development study for SFC separation of polar urinary m
eparation for polar analyte standards spiked into human urine (1:caffeine, 2:cytos
o show the improvement in peak symmetry upon replacement of the BEH 2-EP co
uggested that increasing temperature over this range conferredno
igniﬁcant advantage in terms of chromatographic performance;
o consistent trends were discernable even when the tempera-
ure behaviour of individual columns or co-solvents (Fig. S2C and
respectively) was inspected. Accordingly, the temperature range
as extendedby testingoneadditional temperature, 55 ◦C,which is
till below the maximum temperature recommended for the UPC2
olumns. Only the Torus columns were screened at this higher
emperature; the results are illustrated in Fig. 6. While changing
emperature from 35 to 45 ◦C did not signiﬁcantly alter the median
eak widths or total resolution, increasing temperature to 55 ◦C
esulted in a 3 s drop in median base width (from 17.2 s at 35 ◦C to
4.3 s at 55 ◦C). However, median Rs values did not improve over
he same temperature range, perhaps since most analytes eluted
arlier at 55 ◦C, so reducing resolution (Fig. 6C).
The reduction in median peak width at 55 ◦C was also observed
or each column evaluated at this temperature (Fig. 6D). Together,
hese results suggest that peak capacity may be improved by
ncreasing column temperature to 55 ◦C, but that such an increase
hould be carefully weighed against the possible reduction in
bsolute resolution that accompanies the temperature change.
n addition, since the highest recommended temperature for the
orus columns is 60 ◦C, it may be wise to select a lower oper-
ting temperature to ensure column stability over the course of
igh-throughput metabolomics experiments.
1 ‘Repeatability’ is used here rather than ‘reproducibility’ following NIST recom-
endations for use of these terms [43].lites. A illustrates the effect of column and modiﬁer selection on chromatographic
d 3:uridine); in B, the cytosine peak from each separation shown in A is magniﬁed,
ith the Torus Diol column.
3.2.4. Analytical repeatability1
Within-day analytical precision was measured by monitoring
the retention time and peak area variation of caffeine (present
in each test mixture as an internal standard). The caffeine peak
eluted relatively early in all conditions,when themobile phase con-
sistedpredominantlyofCO2 (rather than theorganicmodiﬁer). This
meant that the caffeine peak was also more susceptible to spray-
pulsing or spray stability phenomena seen at the MS inlet in high
percentages of CO2, and thus functioned as a sensitive indicator
of such problems. As shown in Figs. S3 and S4, while the varia-
tion in retention time (as measured by% RSD) was generally quite
small, at <2% in all conditions, the area of the caffeine peak varied
signiﬁcantly both across modiﬁers and column types. Ammonium
hydroxidehad thehighestmedian caffeinepeak area variationof all
the MS-compatible additives (16.3% vs. 10.0% for ammonium for-
mate),meaning that the improvements in resolution obtainedwith
this additive were accompanied by increased analytical variation.
Surprisingly, both Diol and 2-PIC columns, with narrow peaks and
higher sum of resolution, showed the highest variation in median
caffeinepeakarea (16.9and13.9% respectively). Suchhighvariation
compares unfavourably with the BEH 2-EP column, which has the
lowest peak area RSD of 2.1%. Given the low variability in reten-
tion time values across columns, the large variations in caffeine
peak area were investigated further, and found to be indicative of
spray pulsing into the ESI source. As such, this variation can be
addressed by increasing the percentage of organic modiﬁer in the
mobile phase at the start of the gradient. Preliminary tests show
that increasing the modiﬁer content from 2 to 10% at the start
of the gradient signiﬁcantly reduces the observed variation in the
caffeine peak area, and has the added advantage of reducing the
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radient length without affecting overall separation. Since all of
he tested polar analytes require the presence at least 14% modiﬁer
n the mobile phase for elution, this increase in modiﬁer content is
nlikely to signiﬁcantly reduce the efﬁcacy of the method, even for
arly-eluting analytes.
.2.5. Analysis of human urine extract and polar standards
The method development study described herein indicates that
f the tested Waters columns, the Torus range should be the ﬁrst
hoice for the analysis of any class of polar metabolite; similarly,
he use of either ammonium salts or water as modiﬁer additives
hould be considered when analysing such compounds using SFC.
n order to conﬁrm these ﬁndings, human urinewas analysed using
he 7.35min gradientmethod on the TorusDiol column in the pres-
nce of either 5% water or 20mM ammonium formate in methanol
s amodiﬁer. The resultswere compared to the analysis of the same
rine sample on the BEH 2-EP column using the same set of modi-
ers, since this column is widely used for polar compound analysis
y SFC.
The utility of the ﬁndings from the method development study
re evident in Fig. 7, which shows the pronounced improvement
n peak capacity and overall resolution upon selection of a suitable
odiﬁer additive and column. In Fig. 7A, the use of ammonium for-
ate rather than water as modiﬁer additive resulted in baseline
eparation of uridine and cytosine on the BEH 2-EP column and
mproved resolution on the Diol column; however, when the BEH
-EP column was replaced by the Diol column, both peak shape
Fig. 7B) and resolution improved, regardless of which additive is
sed. Other Torus columns such as the 2-PIC can be used instead of
he Diol without a signiﬁcant loss of resolution or peak symmetry,
nd the combination of ammonium formate and water as modiﬁer
dditives might improve separation more than the use of either
ne by itself. Overall, however, the Torus Diol column used with
methanol/ammonium formate modiﬁer is a promising starting
oint for untargeted SFC analysis of medium polarity metabolites
n urine. This was further conﬁrmed by the elution of 45 out of the
0 compounds in the initial library using this combination of col-
mn and modiﬁer at 40 ◦C (Table S1), i.e. these conditions resulted
n a 75%hit-rate for the polarmetabolite library of interest,with the
ajority of analytes exhibiting excellent peak shapewith little tail-
ng. The majority of analytes which were not detected under these
onditions were organic acids, such as lactic acid, and amino acids
uch, as histidine: in order to detect these, additional optimisation
f MS source or solvent conditions, or the use of MRM analyses,
ay be required. Interestingly, adding both water and ammonium
ormate to the co-solvent resulted in a lower hit-rate of 63%, all
ther conditions (column, temperature etc.) remaining the same;
his suggests that simply combining modiﬁer additives is not suf-
cient to improve performance, but must be accompanied by an
ptimisation procedure for each set of analytes.
. Conclusions
The diversity of the molecular species involved in metabolic
athways is such that nearly any analytical platform is a viable
ool for metabolic phenotyping. For UHPLC–MS based metabolic
roﬁling, RPLC is the preferred mode for the separation of many
on-polar metabolites, such as lipids, while HILIC is often used to
nalyse more hydrophilic compounds; the polarity range covered
y these chromatographicmethods is substantial. Yet proﬁling cer-
ain compoundclasses remains challenging, eitherbecause theyare
oorly retained under RP conditions due to their high polarity, or
ecause a robust HILIC method for the same analytes requires pro-
onged re-equilibration times between analyses [23]. In addition,
oth RP and HILIC methods are dependent on an uninterrupted1449 (2016) 141–155
supply of high-purity organic solvents such as methanol and ace-
tonitrile, which (in a high-throughput environment) can impose
signiﬁcant operational costs associated with solvent purchasing
and disposal. SFC thus offers an alternative to solvent-hungry
LC–MS-based metabolic proﬁling, while simultaneously increasing
the range of analysablemetabolites due to its orthogonality to RPLC
under the appropriate conditions.
The results presented here demonstrate that SFC can indeed be
used to successfully analyse the majority of polar urinary metabo-
lites of interest in the cLogP range from 2 to −7. Of the twelve
columns evaluated, the Torus columns were clearly preferable for
such applications, with the Diol column in particular showing
higher peak capacities (lower peak base widths and higher Rs
values) for all analyte classes, and a somewhat more even dis-
tribution of peaks (higher median r values overall). In addition,
the Torus range has been designed to avoid the pronounced and
continuous retention time shifts observed in SFC using conven-
tional phaseswithmethanolicmodiﬁers (which have recently been
attributed to the formation of methyl silyl ethers under mixed
CO2-methanolic conditions); thus, these columns are most likely
suited for applications with prolonged analysis times [40]. Of the
six MS-compatible additives studied, the ammonium salts gener-
ally resulted in lower base widths and higher overall resolution
than the other additives; however, the increased analytical vari-
ation seen for ammonium hydroxide should be considered when
selecting it as an additive. Alkylamine additives such as isopropy-
lamine should also be considered for UV-active analytes, as these
produced marked reductions in peak widths. However, the signif-
icant increase in peak capacities when using UV–vis detection vs.
MS detection suggests further optimisation of MS settings and/or
the interface between SFC andMS is required. Finally, while the use
of higher temperatures can reduce peak widths for the majority of
columns, the choice of temperature must also be based on stability
considerations for high-throughput experiments.
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